These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28042949)

  • 1. Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.
    Dinsart C; Pervolaraki K; Stroh-Dege A; Lavie M; Ronsse I; Rommelaere J; Van Damme J; Van Raemdonck K; Struyf S
    Hum Gene Ther; 2017 Mar; 28(3):295-306. PubMed ID: 28042949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis.
    Lavie M; Struyf S; Stroh-Dege A; Rommelaere J; Van Damme J; Dinsart C
    Virology; 2013 Dec; 447(1-2):221-32. PubMed ID: 24210118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
    Struyf S; Salogni L; Burdick MD; Vandercappellen J; Gouwy M; Noppen S; Proost P; Opdenakker G; Parmentier M; Gerard C; Sozzani S; Strieter RM; Van Damme J
    Blood; 2011 Jan; 117(2):480-8. PubMed ID: 20980681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
    Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
    Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
    Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
    Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
    Giese NA; Raykov Z; DeMartino L; Vecchi A; Sozzani S; Dinsart C; Cornelis JJ; Rommelaere J
    Cancer Gene Ther; 2002 May; 9(5):432-42. PubMed ID: 11961666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice.
    Haag A; Menten P; Van Damme J; Dinsart C; Rommelaere J; Cornelis JJ
    Hum Gene Ther; 2000 Mar; 11(4):597-609. PubMed ID: 10724038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
    Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
    Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.
    Quemener C; Baud J; Boyé K; Dubrac A; Billottet C; Soulet F; Darlot F; Dumartin L; Sire M; Grepin R; Daubon T; Rayne F; Wodrich H; Couvelard A; Pineau R; Schilling M; Castronovo V; Sue SC; Clarke K; Lomri A; Khatib AM; Hagedorn M; Prats H; Bikfalvi A
    Cancer Res; 2016 Nov; 76(22):6507-6519. PubMed ID: 27634764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.
    Van Raemdonck K; Berghmans N; Vanheule V; Bugatti A; Proost P; Opdenakker G; Presta M; Van Damme J; Struyf S
    Oncotarget; 2014 Nov; 5(21):10916-33. PubMed ID: 25373734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
    Vandercappellen J; Noppen S; Verbeke H; Put W; Conings R; Gouwy M; Schutyser E; Proost P; Sciot R; Geboes K; Opdenakker G; Van Damme J; Struyf S
    J Leukoc Biol; 2007 Dec; 82(6):1519-30. PubMed ID: 17827342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.
    Van Raemdonck K; Gouwy M; Lepers SA; Van Damme J; Struyf S
    Angiogenesis; 2014 Jul; 17(3):631-40. PubMed ID: 24469069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.
    Dempe S; Lavie M; Struyf S; Bhat R; Verbeke H; Paschek S; Berghmans N; Geibig R; Rommelaere J; Van Damme J; Dinsart C
    Cancer Immunol Immunother; 2012 Nov; 61(11):2113-23. PubMed ID: 22576056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
    Marginean A; Sharma-Walia N
    Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
    Moehler M; Blechacz B; Weiskopf N; Zeidler M; Stremmel W; Rommelaere J; Galle PR; Cornelis JJ
    Cancer Gene Ther; 2001 Mar; 8(3):158-67. PubMed ID: 11332986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative distribution and biological characterization of CXCL4L1 isoforms in platelets from healthy donors.
    Ruytinx P; Janssens R; Berghmans N; Gouwy M; Ronsse I; Liekens S; Proost P; Van Damme J; Struyf S
    Biochem Pharmacol; 2017 Dec; 145():123-131. PubMed ID: 28859966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo.
    Lacroix J; Kis Z; Josupeit R; Schlund F; Stroh-Dege A; Frank-Stöhr M; Leuchs B; Schlehofer JR; Rommelaere J; Dinsart C
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29865280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
    Olijslagers S; Dege AY; Dinsart C; Voorhoeve M; Rommelaere J; Noteborn MH; Cornelis JJ
    Cancer Gene Ther; 2001 Dec; 8(12):958-65. PubMed ID: 11781658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional divergence between 2 chemokines is conferred by single amino acid change.
    Dubrac A; Quemener C; Lacazette E; Lopez F; Zanibellato C; Wu WG; Bikfalvi A; Prats H
    Blood; 2010 Nov; 116(22):4703-11. PubMed ID: 20688960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.